succinyldisalicylic acid has been researched along with Hemorrhagic Shock in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, T; Messmer, K; von Dobschuetz, E | 1 |
| Barrett, J; Nagy, K; Sloan, EP | 1 |
1 review(s) available for succinyldisalicylic acid and Hemorrhagic Shock
| Article | Year |
|---|---|
A proposed consent process in studies that use an exception to informed consent.
Topics: Aspirin; Emergency Treatment; Guidelines as Topic; Humans; Informed Consent; Injury Severity Score; Mental Competency; Patient Selection; Presumed Consent; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Shock, Hemorrhagic; Trauma Centers; United States | 1999 |
1 other study(ies) available for succinyldisalicylic acid and Hemorrhagic Shock
| Article | Year |
|---|---|
Diaspirin cross-linked hemoglobin effectively restores pancreatic microcirculatory failure in hemorrhagic shock.
Topics: Acid-Base Equilibrium; Animals; Aspirin; Blood Substitutes; Cell Adhesion; Cross-Linking Reagents; Endothelium, Vascular; Hematocrit; Hemoglobins; Lactic Acid; Leukocytes; Lipid Peroxidation; Male; Microcirculation; Pancreas; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Shock, Hemorrhagic; Thiobarbituric Acid Reactive Substances | 1999 |